CME Group Inc (CME) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.

Total Cash From Operating Activities Chart for CME Group Inc

CME Group Inc (CME) operating cash flow for FY2025 was USD 4.3B, a 15.9% change from FY2024. CME Group Inc's operating cash flow grew from USD 33.0M in 2000 to USD 4.3B in 2025 (12873.1% over 25 years). Operating cash flow compound annual growth rate: 5-year CAGR of 9.5%, 10-year CAGR of 10.9%, 20-year CAGR of 12.7%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$95.04B
Implied Share Price
$264.32
Enterprise Value
$95.58B
Revenue (TTM)
$6.76B
EBITDA
$4.77B
Profit Margin
63.44%
Trailing P/E
22.48
Forward P/E
21.46
Price/Book (MRQ)
3.56
Price/Sales (TTM)
14.07
EV/EBITDA
15.67
EV/Revenue
14.11
Dividend Yield
1.93%
Book Value
$73.82
Free Cash Flow (FY2025)
$4.19B
Free Cash Flow Yield
4.41%

Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.